JP2006525316A5 - - Google Patents

Download PDF

Info

Publication number
JP2006525316A5
JP2006525316A5 JP2006507486A JP2006507486A JP2006525316A5 JP 2006525316 A5 JP2006525316 A5 JP 2006525316A5 JP 2006507486 A JP2006507486 A JP 2006507486A JP 2006507486 A JP2006507486 A JP 2006507486A JP 2006525316 A5 JP2006525316 A5 JP 2006525316A5
Authority
JP
Japan
Prior art keywords
agent component
active agent
dosage form
adverse
transdermal dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006507486A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006525316A (ja
JP4897479B2 (ja
Filing date
Publication date
Priority claimed from US10/744,996 external-priority patent/US7182955B2/en
Application filed filed Critical
Publication of JP2006525316A publication Critical patent/JP2006525316A/ja
Publication of JP2006525316A5 publication Critical patent/JP2006525316A5/ja
Application granted granted Critical
Publication of JP4897479B2 publication Critical patent/JP4897479B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2006507486A 2003-04-30 2004-03-23 濫用抵抗性経皮的剤形 Expired - Fee Related JP4897479B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US46723503P 2003-04-30 2003-04-30
US60/467,235 2003-04-30
US10/744,996 US7182955B2 (en) 2003-04-30 2003-12-23 Abuse-resistant transdermal dosage form
US10/744,996 2003-12-23
PCT/US2004/008857 WO2004098576A1 (en) 2003-04-30 2004-03-23 Abuse-resistant transdermal dosage form

Publications (3)

Publication Number Publication Date
JP2006525316A JP2006525316A (ja) 2006-11-09
JP2006525316A5 true JP2006525316A5 (https=) 2007-05-10
JP4897479B2 JP4897479B2 (ja) 2012-03-14

Family

ID=33313651

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006507486A Expired - Fee Related JP4897479B2 (ja) 2003-04-30 2004-03-23 濫用抵抗性経皮的剤形

Country Status (6)

Country Link
US (1) US7182955B2 (https=)
EP (1) EP1620080B1 (https=)
JP (1) JP4897479B2 (https=)
AU (2) AU2004237580A1 (https=)
CA (1) CA2523425A1 (https=)
WO (1) WO2004098576A1 (https=)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형
US20040219195A1 (en) * 2003-04-30 2004-11-04 3M Innovative Properties Company Abuse-resistant transdermal dosage form
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
JP2008510713A (ja) * 2004-08-20 2008-04-10 スリーエム イノベイティブ プロパティズ カンパニー 半透明保護フィルムを有する経皮薬物送達デバイス
JP5254616B2 (ja) 2004-09-13 2013-08-07 クロノ セラピューティクス、インコーポレイテッド 生物学的同調性（ｂｉｏｓｙｎｃｈｒｏｎｏｕｓ）経皮的薬物送達
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US7827983B2 (en) * 2004-12-20 2010-11-09 Hewlett-Packard Development Company, L.P. Method for making a pharmaceutically active ingredient abuse-prevention device
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential
BRPI0619806A2 (pt) * 2005-12-13 2011-10-18 Biodelivery Sciences Int Inc dispositivo para fornecimento de fármacos transmucosal resistente ao abuso
US7740879B2 (en) * 2006-01-17 2010-06-22 Harrogate Holdings Abuse resistant transdermal drug delivery patch
WO2007103775A2 (en) * 2006-03-03 2007-09-13 Washington University In St. Louis Biomaterials having nanoscale layers and coatings
DE102006025282A1 (de) 2006-05-31 2007-12-20 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System
US20080008747A1 (en) * 2006-07-07 2008-01-10 Royds Robert B Transdermal patch
US20110150766A1 (en) * 2006-07-07 2011-06-23 Royds Robert B Transdermal patch with fatal overdose protection
RU2504377C2 (ru) 2006-07-21 2014-01-20 БайоДеливери Сайенсиз Интэнэшнл, Инк. Способ трансмукозальной доставки лекарства, средство трансмукозальной доставки лекарства (варианты) и способ лечения боли
DE502008001671D1 (de) * 2007-08-21 2010-12-09 Lohmann Therapie Syst Lts Verfahren zum mehrspurigen konfektionieren transdermaler therapeutischer pflaster
EP2259780A2 (en) * 2008-02-28 2010-12-15 Syntropharma Limited Pharmaceutical composition comprising naltrexone
DE102008016804B4 (de) 2008-04-02 2012-01-05 Lts Lohmann Therapie-Systeme Ag Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung
DE102009036485B4 (de) 2009-08-07 2012-10-04 Lts Lohmann Therapie-Systeme Ag Mittel zur zerstörenden Entsorgung von medizinischen Wirkstoffen in transdermalen therapeutischen Systemen
EP2552425B1 (en) * 2010-04-02 2016-07-27 Buzzz Pharmaceuticals Limited Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
MX352959B (es) 2011-08-18 2017-12-15 Biodelivery Sciences Int Inc Dispositivos mucoadhesivos resistentes al abuso para el suministro de buprenorfina.
TW201338813A (zh) * 2011-12-12 2013-10-01 洛曼治療系統股份有限公司 經皮遞送系統
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US10646452B2 (en) 2013-03-15 2020-05-12 New Jersey Institute Of Technology System and method for fabrication of uniform polymer films containing nano and micro particles via continuous drying process
WO2014195352A1 (en) 2013-06-04 2014-12-11 Lts Lohmann Therapie-Systeme Ag Transdermal delivery system
WO2016040695A1 (en) 2014-09-10 2016-03-17 C.R. Bard, Inc. Protective dressing for skin-placed medical device
US10010543B1 (en) 2014-12-23 2018-07-03 Barr Laboratories, Inc. Transdermal dosage form
JP2018511355A (ja) 2015-01-28 2018-04-26 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 薬剤送達方法及びシステム
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
US20170273974A1 (en) 2016-03-24 2017-09-28 Medrx Co., Ltd Patch preparations with misuse prevention features
CN108883078B (zh) * 2016-03-24 2022-09-09 美德阿利克斯株式会社 具有防止误用特性的贴剂
EP3565617A1 (en) 2017-01-06 2019-11-13 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
US9731103B1 (en) 2017-01-13 2017-08-15 Berkshire Biomedical, LLC Computerized oral prescription administration devices and associated systems and methods
US10792226B2 (en) 2017-06-07 2020-10-06 Berkshire Biomedical, LLC Refill and dosage management devices and associated systems and methods for use with computerized oral prescription administration devices
US10441509B2 (en) 2018-03-16 2019-10-15 Berkshire Biomedical, LLC Computerized oral prescription administration with refillable medication dispensing devices and associated systems and methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited METHODS AND SYSTEMS FOR DRUG DELIVERY
WO2020009685A1 (en) * 2018-07-02 2020-01-09 John Tang Transdermal dosage form
WO2020008366A1 (en) * 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal dosage form
WO2020008370A1 (en) 2018-07-02 2020-01-09 Clexio Biosciences Ltd. Transdermal patch
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
EP3899966A1 (en) * 2018-12-18 2021-10-27 Johnson & Johnson Consumer Inc. Personalized topical application patch
US10729860B1 (en) 2019-05-22 2020-08-04 Berkshire Biomedical, LLC Computerized oral prescription administration for securely dispensing a medication and associated systems and methods
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1602344A (en) * 1924-01-09 1926-10-05 Eagle Peter Medicating compress
US2807262A (en) * 1952-12-10 1957-09-24 Robert B Lew Perforated plastic adhesive tape bandage
US3773955A (en) * 1970-08-03 1973-11-20 Bristol Myers Co Analgetic compositions
US4457933A (en) * 1980-01-24 1984-07-03 Bristol-Myers Company Prevention of analgesic abuse
US4539256A (en) * 1982-09-09 1985-09-03 Minnesota Mining And Manufacturing Co. Microporous sheet material, method of making and articles made therewith
JPS5959734A (ja) * 1982-09-30 1984-04-05 Nitto Electric Ind Co Ltd 液状活性物質含有膜及びその製造方法
US4693776A (en) * 1985-05-16 1987-09-15 Minnesota Mining And Manufacturing Company Macromer reinforced pressure sensitive skin adhesive
US4666441A (en) * 1985-12-17 1987-05-19 Ciba-Geigy Corporation Multicompartmentalized transdermal patches
US4917688A (en) * 1987-01-14 1990-04-17 Nelson Research & Development Co. Bandage for transdermal delivery of systemically-active drug
DE3722775A1 (de) * 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
US5474783A (en) * 1988-03-04 1995-12-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
JPH01254621A (ja) * 1988-04-01 1989-10-11 Terumo Corp 薬剤担体および徐放性薬剤ならびにそれらの製造方法
US5236714A (en) * 1988-11-01 1993-08-17 Alza Corporation Abusable substance dosage form having reduced abuse potential
US5149538A (en) * 1991-06-14 1992-09-22 Warner-Lambert Company Misuse-resistive transdermal opioid dosage form
US5756117A (en) * 1992-04-08 1998-05-26 International Medical Asscociates, Inc. Multidose transdermal drug delivery system
CA2173855C (en) * 1993-10-29 2007-06-26 Mieczyslaw H. Mazurek Pressure-sensitive adhesives having microstructured surfaces
US5494680A (en) * 1993-12-08 1996-02-27 Minnesota Mining And Manufacturing Company Transdermal delivery device
WO1997004835A1 (de) 1995-07-28 1997-02-13 Novartis Ag Transdermales system
JPH09151138A (ja) * 1995-11-29 1997-06-10 Toray Ind Inc 薬剤徐放性積層体
US6103258A (en) 1996-04-12 2000-08-15 Simon; David Lew Salts and bases of the 17-(Cyclopropylmethyl)-4,5 alpha-epoxy-6-Methylenemorphinan-3,14 diol molecule for optimizing dopamine homeostasis during administration of opioid analgesics
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
US20020119187A1 (en) * 2000-09-29 2002-08-29 Cantor Adam S. Composition for the transdermal delivery of fentanyl
ATE364380T1 (de) * 2001-03-16 2007-07-15 Alza Corp Transdermales pflaster zur verabreichung von fentanyl
SI2062573T1 (sl) 2001-05-01 2012-02-29 Euro Celtique Sa Proti zlorabi odporni transdermalni sistemi, ki vsebujejo opioid
CA2446738C (en) 2001-05-11 2012-05-29 Endo Pharmaceuticals, Inc. Abuse-resistant opioid dosage form
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
EP1395224A4 (en) 2001-05-22 2005-10-26 Euro Celtique INVIOLABLE ORAL DOSAGE FORM
US7125561B2 (en) 2001-05-22 2006-10-24 Euro-Celtique S.A. Compartmentalized dosage form
US20030157168A1 (en) 2001-08-06 2003-08-21 Christopher Breder Sequestered antagonist formulations
IL160222A0 (en) 2001-08-06 2004-07-25 Euro Celtique Sa Opioid agonist formulations with releasable and sequestered antagonist
TW200404581A (en) * 2002-04-23 2004-04-01 Alza Corp Transdermal analgesic systems with reduced abuse potential
DK1530469T3 (da) * 2002-08-20 2009-05-04 Euro Celtique Sa Transdermal dosisform omfattende et aktivt middel og et salt og fri baseform af en antagonist
KR101159828B1 (ko) * 2003-04-30 2012-07-04 퍼듀 퍼머 엘피 활성제 구성요소 및 활성제 층의 원위부에 억제제 구성요소를 포함하는 내변조성 경피제형

Similar Documents

Publication Publication Date Title
JP2006525316A5 (https=)
del Consuelo et al. Ex vivo evaluation of bioadhesive films for buccal delivery of fentanyl
US6465709B1 (en) Exothermic bandage
ES2245649T3 (es) Un sistema de entrega de farmaco dual adhesivo transdermico.
JP2006525315A5 (https=)
US9849270B2 (en) Foldable adhesive composite dressing
TWI466662B (zh) 皮膚貼附積層體
TWI454249B (zh) 用於治療或預防甲癬或足癬之壓敏膠黏劑基質藥貼裝置
JPWO1995016440A1 (ja) 経皮投与用パッチ製剤
WO2007116959A1 (ja) マイクロニードルデバイスおよびマイクロニードル付き経皮薬物投与装置
CN1170360A (zh) 具有粘性贴面和剥离密封圆片的经皮输送系统
JP2018513121A5 (https=)
WO2005112984A3 (en) Apparatus and method for transdermal delivery of parathyroid hormone agents
CN101146523B (zh) 透皮给药系统
JP5137286B2 (ja) フェンタニル含有口腔粘膜貼付剤
JPH0679002A (ja) 経皮投与用パッチシステム
JP2002531488A5 (https=)
JPH08502727A (ja) プリントされた経皮薬剤送達デバイス
WO2004012676A3 (en) Drug-loaded biological material chemically treated with genipin
WO2004098568A3 (en) Tamper-resistant transdermal dosage form comprising an active agent component and an adverse agent component at the distal site of the active agent layer
TW200602099A (en) Apparatus and method for transdermal delivery of fentanyl-based agents
KR101583680B1 (ko) 펜타닐의 1일-1회 교체 경피 투여
US20070248657A1 (en) Multi-compartment transdermal pain control device
JP2010528064A (ja) 経皮タバコアルカロイドリザーバパッチ
WO2006089056A3 (en) Apparatus and method for transdermal delivery of erythropoetin-based agents